Biotecnología

Biotecnología

Azzur Group Introduces Analytical Laboratory Testing Services
22/02/2024 - Aims to enable industry pioneers in the delivery of novel cell and gene therapies.
SCHOTT Pharma Introduces EVERIC Freeze Vials for Deep-Cold Storage
08/02/2024 - Optimized for vaccines, such as gene therapy and mRNA medications at temperatures down to -80°C.
Human Gene Therapy Products Incorporating Human Genome Editing
06/02/2024 - This is the guidance Human Gene Therapy Products Incorporating Human Genome Editing
VGXI Joins Forces with Resilience to Advance Cell and Gene Therapy Manufacturing
01/02/2024 - The partnership aims to enhance Resilience's efficiency and overall capacity to meet the growing demand in the Cell and Gene Therapy sector.
Ginkgo Bioworks, Biogen Complete Gene Therapy Collaboration
19/01/2024 - Achieves goal of enhancing the AAV production titers of Biogen's gene therapy manufacturing processes.
Charles River Launches Rep/Cap Plasmids
19/01/2024 - Designed to streamline adeno-associated virus (AAV)-based gene therapy programs.
CordenPharma, pHLIP Partner on RNA & Gene Therapies
19/01/2024 - Aims to develop and manufacture small molecule drug payloads directly conjugated with (pHLIP) peptides.
Andelyn Biosciences Chosen for Late-Stage PPQ Mfg. of Gene Therapy
19/12/2023 - Andelyn has successfully manufactured GMP supply of UX111 for patient dosing and will perform PPQ batches for any future regulatory filings.
Visgenx, Charles River Expand Gene Therapy Manufacturing Alliance
15/12/2023 - Charles River will manufacture investigational gene therapy treatment for dry age-related macular degeneration.
RoslinCT to Manufacture CRISPR-based Gene Therapy CASGEVY
12/12/2023 - Approved by the FDA in December 2023 for the treatment of sickle cell disease.
Charles River, GC4K Enter Gene Therapy Mfg. Pact
29/11/2023 - Will leverage Charles River’s plasmid platform, eXpDNA, and premier expertise in plasmid DNA production.
Cellular, Tissue, and Gene Therapies Advisory Committee April 15, 2021 Meeting Announcement - 04/15/2021
24/11/2023 - This is the CBER Cellular, Tissue, and Gene Therapies Advisory Committee April 15, 2021 Meeting Announcement.
Ajinomoto to Acquire Forge Biologics for $620M
14/11/2023 - Acquisition extends global capabilities and diversifies its CDMO services in AAV and plasmid gene therapy manufacturing.
Andelyn, Ohio State Partner on GMP Mfg. of Novel Gene Therapies
13/11/2023 - Will target neurological disorders from concept through to manufacturing for clinical trials.
Cellular, Tissue and Gene Therapies Advisory Committee May 8, 2020 Meeting Announcement - 05/08/2020
07/11/2023 - This is the main page for the CBER Cellular, Tissue and Gene Therapies Advisory Committee May 8, 2020 Meeting Announcement.
ViroCell, Great Ormond Street Hospital Partner to Unlock Clinical Trial Backlog
02/11/2023 - MHRA license will enable global reach of ViroCell’s viral vectors for cell and gene therapy clinical trials.
Sanofi Invests $30M in Gene Therapy Company MeiraGTx
31/10/2023 - Sanofi receives right of first negotiation to use MeiraGTx’s Riboswitch gene regulation technology for certain immunology, CNS, and metabolic targets.
OBiO, Refreshgene Partner on Commercialization of Gene Therapy
27/10/2023 - OBiO will leverage its capabilities of process development, large-scale cGMP commercial production and global business development.
KKR, Flerie Form Specialized Pharma Services Platform with Investment in Coriolis Pharma
27/10/2023 - To extend Coriolis’ position in formulation development and analytical services for innovative high-value biologics, cell and gene therapy products.
Andelyn, Purespring Partner to Advance Gene Therapies for Kidney Diseases
24/10/2023 - Will leverage Andelyn’s suspension platform to manufacture its preclinical and clinical gene therapy products.
eXmoor Opens GMP Facility in the UK
19/10/2023 - Cell and gene therapy Center will help developers take advanced therapies from concept to clinic.